monoclonal antibody
-
Research updates, January 27
A large prospective cohort study published in Infectious Diseases found that a majority of people with Long COVID did not recover.
-
Research updates, September 16
An estimated 36% of people with a documented SARS-CoV-2 infection worldwide have experienced Long COVID, according to a new systematic review that synthesized over 400 studies.
-
No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential
While three early clinical trials of these drugs did not find they led to health improvements for participants, further trials are getting more intentional in targeting viral persistence.
-
Research updates, May 20
Early results from a Long COVID clinical trial assessing the monoclonal antibody AER002 found no difference between those who got the drug and placebo. Researcher Michael Peluso revealed the results at the PolyBio Spring Symposium; he and his colleagues are still analyzing data and will publish a paper later.
-
Invivyd Chairman Marc Elia: The bureaucracy is killing people with Long COVID
The Biden administration failed to prioritize innovative solutions that could alleviate or prevent the worsening of this crisis. Instead, they relied on short-acting, marginally-effective COVID-19 vaccines while restricting the development and availability of new medicines that could dramatically change health outcomes for millions.
-
Research updates, February 11
-
Frustrations, denials, long drives: Immunocompromised people can’t access a lifesaving Covid-19 drug
A new drug approved months ago to help prevent Covid-19 infections could be a game changer for high-risk people — if they can get their hands on it. But many say they have struggled to access the medication.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance